- Home
- ILMN vs CBOE Comparison
ILMN vs CBOE Comparison
Compare ILMN & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ILMN | CBOE |
|---|---|---|
| Founded | 1998 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 25.6B |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ILMN | CBOE |
|---|---|---|
| Price | $134.20 | $253.22 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 11 |
| Target Price | $114.93 | ★ $244.64 |
| AVG Volume (30 Days) | ★ 1.6M | 649.7K |
| Earning Date | 10-30-2025 | 10-31-2025 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 26.68 |
| EPS | 4.46 | ★ 9.30 |
| Revenue | $4,288,000,000.00 | ★ $4,617,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.08 | $5.52 |
| P/E Ratio | $30.24 | ★ $27.21 |
| Revenue Growth | N/A | ★ 16.74 |
| 52 Week Low | $68.70 | $187.30 |
| 52 Week High | $153.06 | $262.98 |
Technical Indicators
Market Signals| Indicator | ILMN | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 69.62 | 51.15 |
| Support Level | $126.44 | $247.68 |
| Resistance Level | $129.72 | $257.23 |
| Average True Range (ATR) | 3.59 | 4.06 |
| MACD | 0.08 | -1.00 |
| Stochastic Oscillator | 85.06 | 42.43 |
Price Performance
Historical ComparisonAbout ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.